| Safety and
effectiveness are two major issues concerned by healthcare
practitioners and public.
The National Heart, Lung, and Blood Institute (NHLBI)
of the National Institutes of Health (NIH) has stopped
early a major clinical trial of the risks and benefits
of Hormone Replacement Therapy (HRT) due to an increased
risk of invasive breast cancer. (link to NIH, HRT issue)
In addition, the National Toxicology Program (NTP),
within the U.S. Department of Health and Human Services,
listed "estrogen" as a human carcinogen on
"the
10th report on Carcinogens (12/11/02)."
Although many people turned to soy products as an alternative,
more researchers start to believe soy-based diets do
not improve menopause symptoms. A new study finds that
the health benefits attributed to soy protein may not
depend on the isoflavone content. (link to soy issues)
Every OsteoPeak¢ç contains OsteoPeak¢ç
Proprietary Blend, herbal extract blend of Rehmannia
glutinosa Libosch and Eleutherococcus senticosus Max.
Iinstead "OsteoPeak¢ç Proprietary Blend
is a hormone-free and estrogen-free herbal blend. Also,
it is scientifically proven to enhance bone-formation
and inhibit bone-destruction. Recently, a decisive study
proved that "500mg of calcium outperformed other
products containing 1000mg and above of calcium in promoting
bone health". (link to media, nutraingredient) |